3rd-Gen TKIs Perform Well in EGFR-Mutated Lung Cancer (CME/CE)

(MedPage Today) -- AZD9291 and rociletinib linked to tumor response and disease control.
Source: MedPage Today Pulmonary - Category: Respiratory Medicine Source Type: news